Mutant IDH-mediated epigenetic dysregulation leads to chondrocyte differentiation of mesenchymal stem cells and downregulation of osteogenic markers, which may explain the high and low prevalence of IDH mutations in chondrosarcoma and osteosarcoma respectively (10). Here, IDH2 is linked to chondrosarcoma.